HNSBF News and Press, Hansa Biopharma AB From 07/17/25

2025-07-17 10:46:16 ET Hansa Biopharma AB (publ) (HNSBF) Q2 2025 Earnings Conference Call July 17, 2025, 8:00 AM ET Company Participants C. Evan Ballantyne - CFO & Senior VP Hitto Kaufmann - Senior VP, Chief R&D Officer Monika Tornsen - COO & Presiden...

2025-07-17 02:47:58 ET More on Hansa Biopharma Hansa Biopharma AB (publ) (HNSBF) Q1 2025 Earnings Call Transcript Hansa Biopharma AB (publ) 2025 Q1 - Results - Earnings Call Presentation Historical earnings data for Hansa Biopharma Financial information for H...

2025-04-24 13:39:43 ET Hansa Biopharma AB (publ) (HNSBF) Q1 2025 Earnings Conference Call April 24, 2025 08:00 AM ET Company Participants Peter Nicklin - Chairman of the Board Hitto Kaufmann - Chief R&D Officer Evan Ballantyne - Chief Financial Officer Re...

2025-04-24 05:58:29 ET More on Hansa Biopharma Hansa Biopharma AB (HNSBF) Q4 2024 Earnings Call Transcript Hansa Biopharma sees 2025 growth through expanded IDEFIRIX adoption and new market reimbursements Historical earnings data for Hansa Biopharma Financial...

2025-02-06 13:13:33 ET More on Hansa Biopharma Hansa Biopharma AB (HNSBF) Q4 2024 Earnings Call Transcript Historical earnings data for Hansa Biopharma Financial information for Hansa Biopharma Read the full article on Seeking Alpha For further detail...

2025-02-06 13:13:06 ET Hansa Biopharma AB (HNSBF) Q4 2024 Earnings Conference Call February 6, 2025 08:00 AM ET Company Participants Soren Tulstrup - President and CEO Evan Ballantyne - Chief Financial Officer Hitto Kaufmann - Chief R&D Officer Conferen...

Hansa Biopharma to attend 2025 J.P. Morgan Healthcare Conference PR Newswire LUND, Sweden , Jan. 7, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" or the "Company" (Nasdaq Stockholm: HNSA), today announced that management will attend the 43 rd Annual J.P. M...